Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE